Nakamura et al. analyzed the failure pattern of definitive chemoradiotherapy in unresectable stage III non‐squamous NSCLC patients (n = 173, including 34 with active EGFR mutations and 13 with positive ALK rearrangement). Here, EGFR is linked to non-small cell lung carcinoma.